her2climb regimen can be used earlier in her2 metastatic breast cancer
Published 3 years ago • 231 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:40
her2climb study shows efficacy in her2 breast cancer with brain metastases
-
2:07
recommendations for her2 testing in metastatic breast cancer
-
5:25
her2climb fda approval
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
3:32
sequencing novel her2-targeted therapies in metastatic breast cancer
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
1:51
tucatinib combination improved survival in her2–positive breast cancer
-
2:34
her2climb: sequencing in metastatic breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
4:01
dual her2 blockade in early breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
5:50
her2climb: investigating tucatinib with capecitabine and trastuzumab in her2-positive metastatic...
-
6:46
treatment options in her2 metastatic breast cancer
-
1:35:31
leveraging targeted therapies to improve outcomes across the continuum of her2 breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
3:22
managing recurrent metastatic er /her2- breast cancer
-
5:55
decision-making in metastatic her2 breast cancer